HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Race For White Oak Almost Over: Will It End With Sharfstein Or Califf At FDA?

This article was originally published in The Tan Sheet

Executive Summary

The Senate confirmation of a permanent FDA commissioner could come as early as March now that the Obama transition team has apparently concluded its search for Andrew von Eschenbach's successor

You may also be interested in...



FDA Commissioner Announcement Complicated By Daschle, Peanut Butter

The withdrawal of Tom Daschle's nomination as Health and Human Services secretary may pose a hurdle to the Obama administration's impetus to name an FDA commissioner, but does not change the two names on the shortlist

HHS Deputy Corr May Reignite FDA Tobacco Oversight; PhRMA Sees Upside

Health and Human Services Secretary-designate Tom Daschle's pick of William Corr as deputy secretary will be a key policy appointment should the Obama administration decide to make FDA regulation of tobacco a priority for the next congressional session

Frank Torti’s Next 100 Days: Active, Not Just Acting FDA Commissioner

Frank Torti might not be in charge of FDA for very long, but he seems determined to make his time count

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS135775

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel